Oxidative stress and biomarker of TNF-α, MDA and FRAP in hypertension
Open Access
- 1 July 2019
- journal article
- Published by S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L in Journal of Medicine and Life
- Vol. 12 (3) , 253-259
Abstract
Concurrent with the misbalance of oxidizing agents and antioxidants, high blood pressure is a major physical burden condition in the current scenario. Tumor necrosis factor-α (TNF-α) plays a vital role in the pathogenesis of hypertension. Tumor necrosis factor-α, inhibitor improves clinical symptoms however their outcome on high blood pressure has not been investigated. We investigated the inflammatory marker TNF-α, malondialdehyde (MDA) and ferric reducing antioxidant power (FRAP) in hypertensive patients. We measured randomly blood pressure using an ambulatory observe in hypertensive patients, measured systolic BP X 140 mmHg and/or diastolic BP X 90 mmHg were considered hypertensive. Total 60 cases were considered in the study that involves 30 hypertensive patients and 30 normal control. Measurements of serum concentrations of TNF-α, MDA, FRAP in hypertension patients was done in both the groups. Serum TNF-α was found to be remarkably increased in study subjects as compared to normal group (r=0.32, p<0.0001*). Serum MDA was also raised in hypertensive as compared to control (r=0.99**, p<0.0001*). While Serum FRAP was found to be decreased in hypertensive group in comparison to healthy control (r=0.23, p<0.0001*). It is concluded that high blood pressure leads to generation of oxidative stress with remarkable elevation of TNF-α and malondialdehyde levels. While reduced FRAP indicates its probable role in lipid peroxidation and in the pathogenesis of hypertension.Keywords
This publication has 31 references indexed in Scilit:
- Nitric Oxide and Malondialdehyde in Human HypertensionAmerican Journal of Therapeutics, 2007
- Clinical pharmacology and therapeutic use of antioxidant vitaminsFundamental & Clinical Pharmacology, 2007
- Reduction of QTc Dispersion by the Angiotensin II Receptor Blocker Valsartan May Be Related to Its Anti-Oxidative Stress Effect in Patients with Essential HypertensionHypertension Research, 2007
- Effect of Salt on Isoprostanes in Salt-Sensitive Essential HypertensionHypertension, 2006
- Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertensionJournal of Human Hypertension, 2005
- Reactive oxygen species in vascular biology: implications in hypertensionHistochemistry and Cell Biology, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential HypertensionJournal of Cardiovascular Pharmacology, 2003
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human AtherosclerosisJournal of Biological Chemistry, 1997